AMREF Health Africa, Health System Advocacy Partnership
1
Amterdam Institute for Global health & Development aighd
1
Analysis Hub
1
and C.J. Arnson
1
and F. Morgado
1
and P. Reijer
1
and R.O'Neill
1
Arantes Beatriz, L. B.
1
Argote P., Barhan E., Zukerman Daly S. et al.
1
Asean Briefing
1
ASEDP (Asociación Salvadoreña para el Estudio y Tratamiento del Dolor y Cuidados Paliativos)
1
Asseburg, M.
1
Assessment Capacities Project ACAPS
1
AWO
1
B. Cao
1
B. Ezenwa
1
B. Mason Meier
1
B. N. Ezenwa, I. B. Fajolu, O. R. Akinajo, et al.
1
BC Centre for Disease Control
1
Bender L.
1
Berger, S.
1
Bham A., J. Bhiman, F. Bongweni et al.
1
Bham, A.
1
Biccard, B.M.
1
Bing Lin A. B., M.L Dietrich, R.A.Senior, et al.
1
Blankenfeld H., H. Kaduszkiewicz, M. M. Kochen et al.
1
BMJ
1
BMJ Open Science
1
Bo Peng , Rowland W. Pettit, and Christopher I. Amos
1
Bozorgmehr, K.
1
British Medical Association BMA
1
British Society for Immunology
1
Budreviciute, A.
1
Bundesgesundheitsblatt
1
Bureau régional de l’OMS pour l’Afrique
1
C. Clift
1
C. Ferreira-Borges
1
C. Hoffmann, et al.
1
C. Perplies
1
C. Victora and M. Chowdury.
1
Camp, R. and C. Hoffmann
1
CAP-China
1
Caqueo-Urízar A., Urzúa A. et al
1
CARE
1
Carrillo-Larco
1
Carruther E., A. Veizis, E. Kondilis, et al.
1
Catholic Agency for Overseas Development CAFOD
1
CDA Collaborative Learning Projects
1
Center for Operational Analysis and Research COAR
1
Center for Public Interest Communications, University of Florida
1
Centers for Disease Control and Prevention
1
Centers for Disease Control and Prevention (CDC)
1
Central Pollution Control Board (Ministry of Environment, Forest & Climate Change)
1
Central Research Institute of Epidemiology of Rospotrebnadzor
1
Centre d’études stratégiques de l’Afrique
1
Centro de Coordinación de Alertas y Emergencias Sanitarias
1
CERAH
1
Cerda A. A., Garcia L. Y.
1
Charles Phiilipe de Lucena AlvesJoão de Deus Barreto Segundo, Gabriel Gonçalves da Costa et al.
1
Cheesbrough, M.
1
China-Japan Friendship Hospital
1
Chu, D.K.
1
Cilliers, J.
1
Civil Society 20 (C20) - Saudi Arabia 2020
1
Clinical Microbiology Reviews
1
Coalition for Epidemic Preparedness Innovations (CEPI)
1
Cobas
1
Cochrane
1
Cochrane Library
1
Collective Service RCCE
1
Columbia University, IFRC, Protection Cluster, et al.
1
Commonwealth of Massachusetts
1
Community Health Impact Coalition
1
Conflict and Health
1
Cook, R.
1
Coregroup
1
COVID-19 Response
1
Cullen M.
1
D. Antognini, A. Combes, et al.
1
D. B. Evans
1
Damiati, S.
1
de Man P, van den Dobbelsteen J, et al.
1
Degam
1
Department for International Development DFID
1
Department of Health & Family Welfare Government of Kerala
1
Department of Health South Africa
1
Dept. of Psychiatry
1
Desogus, A.
1
Deutsche Forschungsgemeinschaft
1
DGVS Paraguay
1
Dheda, K.
1
DHS Program Demographic and Health Surveys
1
DIRECCIÓN GENERAL DE SALUD PÚBLICA, CALIDAD E INNOVACIÓN
1
Dirección General de Vigilancia de la Salud (DGVS)
1
Divya Nair, Nisha Hariharan, Raghav Adlakha, et al.
1
DNDi - Drugs for neglected diseases initiative
1
Dorcas Aid International
1
Doubova SV, Leslie HH, Kruk ME, et al.
1
Dr. J. Breda
1
Dr. med. Thorben Doll, Johannes Pott
1
Dr. P. Amoth
1
Dr. S. K. Kibias
1
Dra. Ximena Garzón et al.
1
E. Levy Yeyati
1
E. Ross
1
E. Webb, M. Mckee et al.
1
E.A Akl, S. Duda, et al.
1
Economist Impact
1
EFSA
1
EFSA Journal
1
Elizabeth Glaser Pediatric AIDS Foundation
1
Emelurumonye I. N., A. Miglietta
1
Emergency Nutrition Network ENN
1
EpiC
1
EQUINET
1
Escritório Regional da OMS para a África
1
ESMAP
1
et al
1
et al.,
1
et. al.
1
Ethiopian Food and Drug Authority
1
Ethiopian Food, Medicine and Healthcare Administration and Control Authority
1
Ethiopian Public Health Institute
1
EU European Union
1
EUAA European Union
1
EuroHealth Observer
1
European & Developing Countries Clinical Trials Partnership EDCTTP
1
European AIDS Clinical Society (EACS)
1
European Asylum Support Office
1
European Centre for disease prevention and Control
1
European Centre for Disease Prevention and Control (ECDC)
1
European Centre for Disease Prevention and Control ECDC, IOM
1
European Commission EC
1
European Investment Bank EIB and UN Development Programme UNDP
1
European Medicines Agency EMA
1
European Observatory on Health Systems and Policies Eurostation
1
European Public Health Alliance
1
European Resuscitation Council ERC
1
European Society of Cardiology
1
European specialist nurse organisation (ESN)
1
European Union EU
1
F. Filippini
1
Fajolu, I.
1
Federal Ministry of Economic Cooperation and Development BMZ
1
Ferraretto, L.A.
1
Ferres M., Potin M.
1
FinalMile
1
Find
1
First Draft, Yale Insitute for Global Health
1
Food and Agriculture Organization of the United Nations FAO and African Union AU
1
Food for the Hungry et al.
1
Foundation for Innovative and New Diagnostics
1
Frase N. S.
1
Fuller, R.
1
Future Learn, ASLM
1
G, Zambrano, E Salgato, F. M. Moyano et al.
1
G.H. Wills, E. Wobudeya, et al.
1
Gabrys, J.
1
Garcia, P.J.
1
GEF
1
Geffert,K., N. Rupp und S. Mauder
1
Gideon
1
Global Dynamics of Social Policy
1
Global Handwashing Partnership
1
Global MediXchange for Combating COVID-19 (GMCC)
1
Global Polio Eradication Initiative (GPEI
1
Global Polio Eradication Initiative GPEI
1
Global Task Force On Cholera Control (GTFCC)
1
GMDAC, University of Potsdam
1
GOAL
1
GOARN
1
GOARN Risk Communication and Community Engagement (RCCE) Coordination Working Group, et al.
1
Goodman, T.
1
Gottlieb N., N. Davidovitch, D. F. Filc et al.
1
Gottlieb, N., M. Hintermeier, K. Bozorgmehr
1
Government of India Ministry of Health & Family Welfare
1
Government of India Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division)
1
Government of Libya, World Health Organization (WHO)
1
Government of lndia Department ol Health Research Ministry of Health & Family Welfare & Director-General, ICMR
1
Government of Malawi
1
Government of Nigeria
1
Government of South Sudan
1
Government of the United Kingdom
1
Government of Zambia
1
Govt. Ethiopia, OCHA
1
Govt. of the State of Palestine
1
Greenhalgh, T.
1
Greinacher, A., et al.
1
Guzman-Vilca, W. C.
1
H. Adler, Gould, S.
1
H. Azizi, G. Dalay and M. Pieper
1
Haarmann, E.
1
Haldane, V., De Foo, C., Abdalla, S.M. et al.
1
Half of Syria
1
Handicap International
1
Hasker E, Hope A, Bottieau E.
1
Hategeka C, Carter SE, Chenge FM, et al.
1
Health Care without Harm
1
Health Cluster
1
Health Cluster & Shelter Cluster Iraq
1
Health Cluster, Nutrition Cluster, OCHA
1
Health Cluster, WHO
1
health Department: Health Republic of South Africa
1
Health Policy and Planning
1
Health Protection Surveillance Centre (HSE)
1
Health Sector Cox Bazar
1
Health Sector Syria
1
Helliwell, John F., Richard Layard, Jeffrey Sachs, and Jan-Emmanuel De Neve
1
HelpAge
1
Hine, P.
1
Honein MA, Christie A, Rose DA, et al.
1
Horizon Medical Education
1
Hospital Divina Providencia
1
Hotline in a Box
1
hpsc
1
Human Resources for Health
1
Human Rights Watch
1
Humanitarian Bulletin Ethiopia
1
Humanitarian Response et al.
1
Humans Rights Watch
1
IACAPAP
1
IAWG on Reproductive Health in Crises, IPPF, JSI, et al.
1
ICMHD
1
IHME Institut for Health Metrics and Evaluation
1
ILO
1
iMMAP
1
Imperial College COVID-19 Response Team
1
Indian Council of Medical Research
1
Indian Council of Medical Research Department of Health Research
1
Iniciativa ETMI-PLUS
1
Institute for Health Metrics and Evaluation
1
Institute for security Studies
1
Institute for Security Studies ISS
1
Inter-Agency Standing Comittee IASC
1
Inter-Agency Standing Committee IASC, et al.
1
Inter-agency Working Group on Reproductive Health in CrisesInternational Rescue Committee
1
InterAction
1
International Committee of the Red Cross ICRC
1
International council of Nurses
1
International Diabetes Federation IDF
1
International Disability and Development Consortium (IDDC)
1
International Organization for Migration
1
International Organization for Migration (IOM)
1
International Organization for Migration IOM (14 - 27 June 2020)
1
International Pharmaceutical Federation (FIP)
1
International Rescue Committee
1
International Rescue Committee, et al.
1
IOM UN Migration
1
IRC
1
Iribarren, S.
1
Irish Aid
1
Istituto Superiore di Sanità (ISS)
1
J. Bhiman, F. Bongweni et al.
1
J. Bueno de Mesquita
1
J. Tjaden
1
J.de D. Barreto Segundo, G.Gonçalves da Costa, et al.
1
JAMIA Open
1
Jara A., Undurraga E. A. et al
1
Jassat, W.
1
Jesuit Worldwide Learning
1
John Hopkins Bloomberg School
1
John Hopkins Center for Communication Programs
1
Johns Hopkins University
1
Julián-Jiménez, A.
1
K. Doerholt
1
K. Freeborn
1
K. Hauck
1
K. Khalid, A.Wharton-Smith, et al.
1
K. Lancaster
1
K. Quy
1
Kaloti R., R. Kafri, H. Meghari
1
Karen LeBan , Maryse Kok and Henry B. Perry
1
Kenya Ministry of Health
1
Khdr Sabir, D. et al.
1
Kim, A.
1
King E. J., N. Zotova
1
Kleynhans, J.
1
Koczulla, A Rembert
1
Kohler, S.
1
Kompetenznetz Public Health zu COVID-19
1
Kuehn, B.M.
1
Kulkarni, S.
1
Kurowski, C.
1
l.
1
L. A Graybill
1
L. Biddle
1
Ladnaya, N.
1
Lancet
1
Lancet Oncology Commission
1
Leon-Velarde, F.
1
lndian Councilof Medical Research
1
Logistics Cluster World Food Programme WFP
1
Logunov, D.Y, et al.
1
Lok Swasthya SEWA Trust and World Health Organization WHO India
1
LSHTM
1
Lucena Alves, C.P. de
1
M. Ballard, Bancroft E., Nesbit J., et al.
1
M. Dara
1
M. Fendt-Newlin, S. T. Al-Harahsheh, et al.
1
M. Langer
1
M. Nebuloni
1
M. Roser, P. Geldsetzer, T. Bärnighausen
1
M. S. Razai
1
Makwe, C.
1
Malawi Human Rights Commission
1
Maman, D.
1
MAMI, Irish Aid, Eleanor Crook Foundation
1
Martini M, M. Abdiker
1
Marty, F.M.
1
Marzouk M., Rayes D., Y. Douedari et al.
1
Massard da Fonseca, E.
1
Mauder, S., K. Geffert
1
MEDBOX Team
1
Meike J. Schleif, Iain Aitken , et al.
1
Millennium Development Goal Acceleration Initiative
1
Milligan H., Goodwin K., et al.
1
Ministerio de Salud Argentina
1
Ministerio de Salud Bolivia
1
Ministerio de Salud El Salvador
1
Ministerio de Salud y Proteccion Social Bogota, Colombia
1
Ministerio de Salud, Colombia
1
Ministery of Health and Familiy Welfare - Government of India
1
Ministery of Health and Family Welfare - Government of India
1
Ministério da Saúde, Brasil
1
Ministério da Saúde, Secretaria de Atenção Primária à Saúde Brasil
1
Ministry of Health
1
Ministry of Health & Family Welfare Directorate General of Health Services (EMR Division)
1
Ministry of Health & Family Welfare Directorate General of Health Services EMR Division
1
Ministry of Health & Family Welfare of Bangladesh, Directorate General of Health Services
1
Ministry of Health & Family Welfare, Goverment of India
1
Ministry of Health and Family Welfare Government of India
1
Ministry of Health and Family Welfare, India
1
Ministry of Health Ghana
1
Ministry of Health Rwanda, The DHS Program, et al.
1
Ministry of Health, Federal Democratic Republic of Ethiopia
1
Ministry of Health, Liberia, World Health Organization (WHO), and Centers for Disease Control and Prevention (CDC)
1
Ministry of Health,Uganda
1
Ministry pf Health and Sanitation Sierra Leone
1
Montelongo, A.
1
Morse, J.M.
1
Mosca D. T., C. Marotta, F. di Gennaro, et al.
1
Msomi, N.
1
Murphy, J.P.
1
Mutale W.
1
N. Petrosillo
1
Nalbandian, A.
1
Nation Institute for Communicable Diseases
1
Nation Institute for Communicable Diseases - Division of the National Health Laboratory Service
1
Nation Institute for Communicable Diseases, South Africa
1
National Academies of Sciences, Engineering, and Medicine
1
National Academy of Medicine
1
National Centre for Disease Control (formerly National Institute of Communicable Diseases)
1
National Department of Health (NDoH) South Africa
1
National Department of Health Directorate: Communicable Diseases
1
National Department of Health South-Africa
1
National Institute for Communicable Diseases (NICD)
1
National Institute of Mental Health & Neurosciences, Bengaluru India
1
National Centre for Disease Control
1
NDoH South Africa
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
Interactive Map
You’ve probably noticed that the map has been evolving along with the virus. Now, it sports new layers of data—including a close-up section on the US, with details on testing, hospitalizations, and country-level demographic data.
The map provides “more nuance on what’s h...appening to support decision-making.
For example, the new details can help prepare hospitals to better anticipate staffing and resource shortagesmore
Guidance issued as of 25 March 2020
This guidance is intended for use by health authorities to guide the actions taken by health-care providers for refugees and migrants in relation to the novel coronavirus (COVID-19) outbreak. This document is intended to address the needs and rights of refugees a...nd migrants living in all types of setting.
General recommendations made by WHO in the COVID-19 response (link here) are the superseding guidelines. Unfounded measures regarding testing, health screening and quarantine should not be imposed on refugees and migrants.more
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t...he COVID-19 outbreak, including how testing might be rationalized in low resource settings. All testing should be followed by a strong public health response including isolating those who test positive and providing them care, contact tracing and quarantine of contacts.more
Horizon Medical Education produce cpd courses for primary care health workers, mainly aimed at LMI's. They have users in Zambia and other countries in the region. The courses are downloadable audio modules supported by written resources and online testing.
In response to the pandemic they are pro...ducing free modules about coronavirus, these include what we currently know, how to treat, some public health messages and myth-busting.more
Refugees and migrants face similar health threats from COVID-19 as their host populations. However, inadequate access to essential services and exclusion may makes early detection, testing, diagnosis, contact tracing and seeking care for COVID-19 difficult for refugees and migrants thus increasing t...he risk of outbreaks in these population and presenting an additional threat to public health. This document offers guidance to Member States and partners for the inclusion of refugees and migrants, as part of holistic efforts to respond to COVID-19 epidemics in the general populations.
17 April 2020more
The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitiga...tion strategies and case management. More and more immunodiagnostics, mostly rapid diagnostic tests, are being made available as an alternative to NAATs. This type of test can be used out-of-laboratory conditions at large scale.more
While many of the countries hit by the COVID-19 in the first few months of the year are now beginning to relax lockdown measures as infection and death rates fall, in the regions most affected by HIV, TB and malaria, such as Africa, South Asia and Latin America, the pandemic continues to accelerate.... In lower resource settings, lockdowns are less effective and hard to sustain, and clinical care facilities are extremely limited. In such environments, the response to COVID-19 must focus on containing the pandemic’s spread as far as possible through testing, contact tracing and isolation, protecting the health workforce through training and the provision of personal protective equipment (PPE) and minimizing the knock-on impact on other diseases through shoring up fragile health systems, and adapting existing disease programs.more
For COVID-19, as for many infectious diseases, the true level of transmission is frequently underestimated because a substantial proportion of people with the infection are undetected either because they are asymptomatic or have only mild symptoms and thus typically fail to present at healthcare fac...ilities. There may also be neglected or under-served segments of the population who are less likely to access healthcare or testing. Under-detection of cases may be exacerbated during an epidemic, when testing capacity may be limited and restricted to people with severe cases and priority risk groups (such as frontline healthcare workers, elderly people and people with comorbidities). Cases may also be misdiagnosed and attributed to other diseases with similar clinical presentation, such as influenza.
Differences in mortality between groups of people and countries are important proxy indicators of relative risk of death that guide policy decisions regarding scarce medical resource allocation during the ongoing COVID-19 pandemic. This document is intended to help countries estimate CFR and, if possible, IFR, as appropriately and accurately as possible, while accounting for possible biases in their estimationmore
The number of confirmed COVID-19 cases detected and reported in each country is influenced by
many factors including limited access and/or utilization of healthcare and COVID-19 testing, limited
surveillance, lack of knowledge amongst the population about when to seek testing, an asymptomatic pres...entation, and other unknown issues. This is true in all countries of the world, and not Africa specific, however there are factors unique to Africa which may also affect the way the virus behaves there. COVID-19 prevalence data are critical for planning effective mitigation strategies and understandingthe true impact of the disease and relevant intervention measures in Africa, which might be quite different from regions with a different population age distribution or risk factor profile.more
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident...ify areas that need further attention to enable the facility to respond effectively to the pandemic. The tool encompasses key components that are essential to managing COVID-19 in a hospital setting, including:
health workforce (numbers, absences, COVID-19 infections, staff vaccinated for COVID-19 health workforce management, training and support);
medicines and medical supplies for management of COVID-19;
IPC capacities (protocols, safety measures, guidelines) and the availability of personal protective equipment (PPE) for staff;
diagnostic testing, imaging and patient monitoring devices and supplies
medical equipment for management of COVID-19, including O2 administration;
COVID-19 vaccine readiness ;
beds and space capacity.more
The report finds that, as of 3 November, in 87 countries with age-disaggregated data, children and adolescents under 20 years of age accounted for 1 in 9 of COVID-19 infections, or 11 per cent of the 25.7 million infections reported by these countries. More reliable, age-disaggregated data on infect...ion, deaths and testing is needed to better understand how the crisis impacts the most vulnerable children and guide the responsemore
Ladnaya, N.; et al.Central Research Institute of Epidemiology of Rospotrebnadzor; et al.
(2020)
C1
Результаты исследования «Изучение распространенности коронавирусной инфекции COVID-19 среди инфицированных ВИЧ пациентов вРоссии ивлияния эпидемии коронавирусной... инфекции COVID-19 на оказание медицинской помощипри ВИЧ-инфекции»
This study shows the negative impact that the COVID-19 pandemic is having on access to HIV care in the Russian Federation and shows that people living with HIV in the country are more susceptible to COVID-19 but less likely to seek testing or treatment.
More than a third of people living with HIV who were surveyed reported some impact on HIV services, including about 4% who reported that they had missed taking antiretroviral therapy because they could not get the medicine and nearly 9% who reported that they had missed taking medicine for tuberculosis prevention. However, the majority of respondents (about 70% of people living with HIV) did not experience problems obtaining antiretroviral therapy and about 22% reported that antiretroviral medicines were delivered to their home. More than 900 respondents from 68 regions of the Russian Federation, including people living with HIV and those who are not, were reached by the study.more
The global pandemic has highlighted fragility in international supply chains and the dependency of many African countries on imported personal protective equipment (PPE). Market pressures have also increased prices for imported supplies and put additional pressure on areas with limited resources for... procurement. There is an urgent operational need to develop the domestic capacity to supply PPE from within the African continent. There is huge variation in Member
States industrial manufacturing capacity and the regulatory and testing capacity of government agencies at present. Growing number of companies, including micro- and small-medium enterprises, have responded by repurposing, albeit temporarily, to manufacture an assortment of PPEs. This workshop aims to bring together government representatives, industry, and subject matter experts on material testing and standards to promote the development of domestic production of safe and effective PPE made in Africa.more
16 Dec. 2020
This document provides guidance to Ministries of Health (MOHs), laboratory personnel and implementing partners in African Union Member States on the application of rapid antigen tests to COVID-19 testing. The guidance serves as reference for policymakers, laboratory leads, implementing... partners, and experts on use case scenarios and associated testing algorithms for COVID-19 antigen tests. It recommends the use of antigen tests to increase access to testing and enable timely results for persons with or without symptoms in specific settings. The document will be reviewed and updated as more evidence becomes available regarding the use of rapid antigen tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from global studies and evaluation efforts.more
18 Janaury 2021
EU/EEA Member States and the UK have increased their laboratory capacity tremendously over the past 11 months as the majority of the Member States reported sufficient testing capacity until March 2021.
Many countries are adding rapid antigen detection tests (RADT) to their ...testing strategies in order to reduce pressure on RT-PCR testing.
Some Member States have already included RADT in their case definition.
The main bottlenecks, such as shortages of laboratory consumables and human resources, as well as sample storing facilities, continue to exist and may affect the overall laboratory response to COVID-19.more
Limited coverage of laboratory services and long turnaround times from real-time reverse transcription-polymerase chain reaction (rRT-PCR) for the detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been insufficient to meet the demands in many African countries in response... to the COVID-19 pandemic. Rapid antigen diagnostic tests (AgRDTs) are potentially useful as they can inform healthcare workers and individuals of their infection status at point-of-care testingmore
WHO has a unique combination of technical public health and scientific expertise, and a global operational footprint, with field offices in more than 150 countries. In 2020, this global, technical, and operational reach meant WHO was able to support countries around the world in every aspect of COVI...D-19 public health response, from surveillance and laboratory testing to maintaining essential health services in the most vulnerable and fragile contexts.more
Over 18 months into the pandemic, WHO continues to conductglobal surveillance of COVID-19as part of activities on preparedness, readiness and response activities. The need for global surveillance of COVID-19 is greater than ever, asthe implementation of vaccination campaigns and the appearance of va...riants are prone to impact the course of the epidemic, as transmission patterns evolve. Timely and complete surveillance data are key to monitoring these changes.
Features include stratification by age and sex, trends over time, case fatality ratios by age, testing, hospitalization, and data on health workers –all visible at country and regional levels. The dashboard provides the ability for users to conduct further analyses by country and selected time period.more
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...se promoting COVID-19 preventive behaviours among young people. Designers of programmes and initiatives targeting youth may find it helpful to refer to the youth-specific barriers and drivers identified in this policy brief and to prioritize these for testing when planning initiatives targeted at young people.more
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline... is available both online and PDF.
**This version of the living guideline (version 5.0) **includes the following seven revised statements for the prevention, identification and management of SARS-CoV-2 infections among health and care workers:
a good practice statement on national and subnational testing strategies;
a good practice statement on passive syndromic surveillance of health and care workers;
a good practice statement on prioritizing health and care workers for SARS-CoV-2 testing;
a good practice statement on protocols for reporting and managing health and care worker exposures;
a good practice statement to limit in-person work of health and care workers with active SARS-CoV-2 infections;
a statement on high-risk exposures and quarantine; and,
a conditional recommendation on the duration of isolation for health and care workers.
Understanding the updated section
Prevention of infections in the health care setting includes a multi-pronged and multi-factorial approach that includes IPC and occupational health and safety measures and adherence to Public Health and Social Measures in the community by the health workforce. The underlying infection prevention and control strategy of this section is the notion that early identification of symptomatic cases, testing and quarantining/isolating health and care workers decreases the risk of nosocomial infection to patients and to other health and care workers.more